All In Biotech

Drug Trial Radar · NCT07446322

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

An Open-Label, Randomized, Multicentre, Phase 2 Study of FOLFIRI + Bevacizumab + Pelareorep vs. FOLFIRI + Bevacizumab for the Second-Line Treatment of Metastatic, RAS-mutated, Microsatellite-Stable (MSS) Colorectal Cancer

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Apr 30, 2026

Primary completion

Aug 30, 2027

Study completion Apr 30, 2030

Sponsor

Lead sponsor
Oncolytics BiotechIndustry
Sponsor type
Industry
First posted
Mar 3, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label, randomized, multicenter Phase 2 study to assess the efficacy and safety of FOLFIRI + bevacizumab + pelareorep vs. FOLFIRI + bevacizumab in patients with RAS-mutated, MSS mCRC who have progressed after one prior line of oxaliplatin-based therapy.

Conditions

  • Ras-mutated Metastatic Colorectal Cancer
  • mCRC
  • MSS Metastatic Colorectal Cancer

Interventions

  • BevacizumabDrug

    Bevacizumab (5 mg/kg) IV infusion

  • FOLFIRIDrug

    irinotecan (180mg/m2), leucovorin 400 mg/m2 ± 5-FU (400 mg/m2) IV infusion

  • PelareorepDrug

    pelareorep 4.5 x 10\^10 TCID50 IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Response Rate (ORR)Time frame: At week 8

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Central Alabama Research

    Homewood, Alabama · Recruiting

  • Clinical Research Advisors (Beverly Hills)

    Beverly Hills, California · Recruiting

  • Clinical Research Advisors (Encino)

    Encino, California · Recruiting

  • Clinical Research Advisors (Korea Town)

    Koreatown, California · Recruiting

  • Clinical Research Advisors (Downtown LA)

    Los Angeles, California · Recruiting

  • Clinical Research Advisors (West Hollywood)

    Los Angeles, California · Recruiting

  • Clinical Research Advisors (West Covina)

    West Covina, California · Recruiting

  • Moffitt Cancer Center

    Tampa, Florida · Recruiting

  • Emory Winship Cancer Institute

    Atlanta, Georgia · Recruiting

  • Beacon Cancer Center

    Post Falls, Idaho · Recruiting

  • Northwestern Memorial Hospital

    Chicago, Illinois · Recruiting

  • Community Health Network

    Indianapolis, Indiana · Recruiting

  • Karmanos Cancer Institute

    Detroit, Michigan · Recruiting

  • Washington University School of Medicine

    St Louis, Missouri · Recruiting

  • Summit Health Cancer Center

    Florham Park, New Jersey · Recruiting

  • Rutgers Cancer Institute

    New Brunswick, New Jersey · Recruiting

  • Gabrail Cancer Center

    Canton, Ohio · Recruiting

  • University of Cincinnati Medical Center

    Cincinnati, Ohio · Recruiting

  • Ohio State University

    Colombus, Ohio · Recruiting

  • The University of Texas MD Anderson Cancer Center

    Houston, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.